Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Catheter EquipmentCardiovascular Device

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1795826

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1795826

Peripheral Interventions

PUBLISHED:
PAGES: 492 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Peripheral Interventions Market to Reach US$16.3 Billion by 2030

The global market for Peripheral Interventions estimated at US$10.8 Billion in the year 2024, is expected to reach US$16.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Atherectomy Intervention, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$6.5 Billion by the end of the analysis period. Growth in the Stent Implantation Intervention segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 10.9% CAGR

The Peripheral Interventions market in the U.S. is estimated at US$2.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 10.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Peripheral Interventions Market - Key Trends & Drivers Summarized

Why Are Peripheral Interventions Gaining Traction in Modern Vascular Therapy?

Peripheral interventions-minimally invasive procedures that treat blockages or abnormalities in blood vessels outside the heart and brain-are becoming an integral part of vascular care as chronic vascular diseases escalate globally. These interventions encompass procedures such as angioplasty, stenting, atherectomy, thrombectomy, embolization, and endovenous ablation. They are employed to manage peripheral artery disease (PAD), deep vein thrombosis (DVT), varicose veins, aneurysms, and arteriovenous malformations.

The surge in PAD cases, attributed to aging populations, diabetes, smoking, and sedentary lifestyles, is fueling demand for catheter-based revascularization techniques that avoid the complications and recovery times associated with open vascular surgery. Endovascular therapy allows for vessel dilation, plaque removal, or clot extraction using low-profile devices guided via femoral, radial, or pedal access. As awareness about early-stage vascular disease improves, more patients are being treated proactively using peripheral intervention before the onset of critical limb ischemia (CLI) or tissue loss.

Non-atherosclerotic vascular conditions such as venous reflux disease, pelvic congestion syndrome, and dialysis access dysfunction are also being increasingly managed using peripheral techniques. The growth of hybrid vascular ORs, outpatient-based labs (OBLs), and interventional radiology suites is enabling greater procedural access and same-day discharge pathways. The shift toward value-based vascular care models is reinforcing the importance of less invasive, cost-effective, and outcome-optimized interventional therapies.

How Are Device Innovations and Imaging Technologies Redefining Outcomes?

Device miniaturization, improved guidewire technology, and enhanced catheter maneuverability have revolutionized peripheral interventions. Drug-coated balloons (DCBs) and drug-eluting stents (DES) have reduced restenosis rates in femoropopliteal and infrapopliteal segments. Atherectomy devices-rotational, orbital, laser, or directional-are being tailored to specific lesion morphologies and calcification patterns, improving plaque debulking and vessel preparation in complex PAD.

Ultrasound and intravascular imaging modalities such as IVUS (intravascular ultrasound) and OCT (optical coherence tomography) are now being deployed to assess lesion characteristics, guide device sizing, and evaluate post-procedural outcomes in real-time. 3D vascular navigation and robotic catheters are also being tested for enhanced procedural control and reproducibility. Embolic protection devices and vessel closure systems are increasing safety margins in high-risk procedures.

In venous interventions, laser and radiofrequency ablation catheters are replacing surgical stripping for varicose vein treatment, providing faster recovery and reduced recurrence. For DVT and pulmonary embolism, mechanical thrombectomy systems like aspiration catheters and rotating baskets are allowing for clot removal without systemic thrombolytics, reducing bleeding risks. Innovations in scaffold materials, biodegradable stents, and sheathless systems are also expanding the anatomical reach and durability of peripheral therapies.

Which Clinical Segments and Regional Markets Are Leading Peripheral Interventional Growth?

Peripheral interventions span a wide range of specialties including interventional cardiology, interventional radiology, vascular surgery, and nephrology. The most significant clinical growth is occurring in PAD management, especially in below-the-knee (BTK) interventions for patients with diabetes or renal disease. Revascularization of long, calcified lesions and treatment of chronic total occlusions (CTOs) are becoming more feasible with specialty crossing devices and low-profile balloons.

The dialysis access segment is another growing niche, where arteriovenous fistula (AVF) stenoses are treated using balloon angioplasty, stent grafts, or thrombectomy to restore flow and preserve access longevity. Endovenous interventions for venous reflux, pelvic venous insufficiency, and post-thrombotic syndrome are also expanding with new embolization coils, adhesives, and sclerosants. Uterine fibroid embolization and prostate artery embolization represent non-oncologic, minimally invasive alternatives to surgery in the reproductive health domain.

Geographically, North America dominates due to high procedural volumes, robust interventional infrastructure, and wide reimbursement coverage. Europe is focused on personalized vascular care pathways and adoption of DCBs and atherectomy systems. Asia-Pacific, particularly China and India, is seeing explosive growth due to rising vascular disease burden, increasing cath lab penetration, and expanding interventional training. Middle Eastern and Latin American markets are gradually adopting peripheral interventions through public-private healthcare investments.

What Is Driving Growth in the Global Peripheral Interventions Market?

The growth in the global peripheral interventions market is driven by the rising prevalence of peripheral vascular disease, rapid technology innovation, increasing adoption of minimally invasive therapies, and the global shift toward outpatient and preventive vascular care. As the burden of chronic vascular conditions rises, particularly in aging and diabetic populations, peripheral interventions offer an effective and efficient treatment paradigm.

Regulatory approvals for newer-generation DCBs, stent platforms, and embolic agents are accelerating procedural adoption. Meanwhile, supportive reimbursement policies, integration of endovascular procedures in outpatient centers, and enhanced cross-specialty training are expanding procedural reach and acceptance. Patient preference for non-surgical interventions, combined with improved long-term outcomes and lower complication risks, further strengthens market momentum.

As vascular care evolves into a data-driven, outcome-focused specialty, peripheral interventions will remain a cornerstone of therapy. The market is poised for continued expansion as healthcare systems prioritize limb preservation, cardiovascular risk reduction, and minimally invasive disease management strategies.

SCOPE OF STUDY:

The report analyzes the Peripheral Interventions market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Intervention Type (Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention, Embolization Intervention); Device Type (Interventional Catheters, Interventional Stents, Guide Wires, Interventional Balloons, Embolic Coils); Indication (Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication, Carotid Artery Stenosis Indication); End-User (Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User, Research Institutes End-User)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories (Abbott Vascular)
  • Bayer AG
  • Biotronik SE & Co KG
  • Boston Scientific Corp.
  • Cardinal Health
  • Cook Medical
  • Cordis (Johnson & Johnson)
  • Edward Lifesciences
  • Getinge AB
  • Inari Medical
  • Johnson & Johnson (Cordis, Biosense)
  • LeMaitre Vascular
  • Medtronic plc
  • Merit Medical Systems
  • NuVasive (spine but vascular tools)
  • Penumbra Inc.
  • Philips (Royal Philips)
  • Reflow Medical
  • Siemens Healthineers
  • Stryker (Inari acquisition)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP39180

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Peripheral Interventions - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Peripheral Artery Disease Throws the Spotlight on Minimally Invasive Interventions
    • Expansion of Aging Population Base Accelerates Demand for Endovascular Treatment Options
    • Technological Advancements in Drug-Eluting Balloons and Stents Drive Product Innovation
    • Growing Adoption of Atherectomy and Thrombectomy Devices Spurs Market Expansion
    • Shift Toward Ambulatory Surgical Centers Strengthens Business Case for Outpatient Peripheral Procedures
    • Integration of Imaging-Guided Navigation Systems Enhances Precision in Peripheral Interventions
    • Rising Incidence of Diabetes and Obesity Drives Need for Lower Limb Revascularization Procedures
    • Expansion of Healthcare Infrastructure in Emerging Markets Propels Access to Peripheral Treatments
    • Increased Reimbursement Support in Developed Markets Boosts Adoption of Endovascular Devices
    • Development of Bioabsorbable and Next-Gen Scaffold Technologies Spurs Device Innovation
    • Vascular Surgeons and Interventional Radiologists Drive Procedural Volume Through Cross-Specialty Growth
    • Patient Preference for Non-Surgical Therapies Expands Addressable Market for Peripheral Interventions
    • Favorable Clinical Trial Outcomes Strengthen Physician Confidence in Device-Based Interventions
    • Growing Focus on Limb Salvage Strategies in Critical Limb Ischemia Supports Market Penetration
    • Integration of Artificial Intelligence in Procedural Planning Enhances Treatment Outcomes
    • Rising Burden of Smoking-Linked Atherosclerotic Disease Fuels Demand for Vascular Access Tools
    • Hospital Consolidation Trends Drive Standardization of Peripheral Vascular Device Procurement
    • Emergence of Robotic and Telerobotic Intervention Systems Expands Technological Frontiers
    • Global Increase in Endovascular Fellowships Supports Skilled Workforce Development
    • Regulatory Fast-Track Approvals for Life-Saving Devices Sustain Innovation in Peripheral Intervention Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Peripheral Interventions Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Peripheral Interventions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Peripheral Interventions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Peripheral Interventions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Atherectomy Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Atherectomy Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Atherectomy Intervention by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Stent Implantation Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Stent Implantation Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Stent Implantation Intervention by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Angioplasty Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Angioplasty Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Angioplasty Intervention by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Thrombectomy Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Thrombectomy Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Thrombectomy Intervention by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Embolization Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Embolization Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Embolization Intervention by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Embolic Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Embolic Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Embolic Coils by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Interventional Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Interventional Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Interventional Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Interventional Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Interventional Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Interventional Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Guide Wires by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Guide Wires by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Guide Wires by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Interventional Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Interventional Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Interventional Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Coronary Artery Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Coronary Artery Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Coronary Artery Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Stroke Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Stroke Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Stroke Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Peripheral Arterial Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Peripheral Arterial Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Peripheral Arterial Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Renal Artery Stenosis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Renal Artery Stenosis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: World 16-Year Perspective for Renal Artery Stenosis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Carotid Artery Stenosis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Carotid Artery Stenosis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: World 16-Year Perspective for Carotid Artery Stenosis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: World 16-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: World 16-Year Perspective for Ambulatory Surgery Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 56: World Recent Past, Current & Future Analysis for Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: World Historic Review for Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: World 16-Year Perspective for Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 59: World Recent Past, Current & Future Analysis for Research Institutes End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: World Historic Review for Research Institutes End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: World 16-Year Perspective for Research Institutes End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 62: USA Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: USA 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: USA 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 68: USA Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: USA Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: USA 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 71: USA Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: USA Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: USA 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Canada 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Canada 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Canada Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Canada 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 83: Canada Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Canada Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Canada 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • JAPAN
    • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Japan 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Japan 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 92: Japan Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Japan Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Japan 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 95: Japan Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Japan Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Japan 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • CHINA
    • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 98: China Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: China 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 101: China Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: China 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 104: China Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: China Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: China 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 107: China Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: China Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: China 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • EUROPE
    • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Peripheral Interventions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Peripheral Interventions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Europe 16-Year Perspective for Peripheral Interventions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Europe 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Europe 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Europe 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Europe 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • FRANCE
    • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 125: France Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: France Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: France 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 128: France Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: France Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: France 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 131: France Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: France Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: France 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 134: France Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: France 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • GERMANY
    • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 137: Germany Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Germany Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Germany 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 140: Germany Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Germany Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Germany 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 143: Germany Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Germany Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Germany 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 146: Germany Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Germany Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Germany 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 149: Italy Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Italy Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Italy 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 152: Italy Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Italy Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Italy 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 155: Italy Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Italy Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Italy 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 158: Italy Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Italy Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Italy 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 161: UK Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: UK Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: UK 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 164: UK Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: UK Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: UK 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 167: UK Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: UK Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: UK 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 170: UK Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: UK Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: UK 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 173: Spain Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Spain Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Spain 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 176: Spain Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Spain Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Spain 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 179: Spain Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Spain Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Spain 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 182: Spain Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Spain Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Spain 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 185: Russia Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Russia Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Russia 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 188: Russia Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Russia Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Russia 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 191: Russia Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Russia Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Russia 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 194: Russia Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Russia Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Russia 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Europe Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Europe 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Europe Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Europe 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Europe Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Europe 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Europe Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Europe 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Peripheral Interventions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Asia-Pacific 16-Year Perspective for Peripheral Interventions by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Asia-Pacific Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Asia-Pacific 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Asia-Pacific Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Asia-Pacific 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Asia-Pacific Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Asia-Pacific 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Asia-Pacific Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Asia-Pacific 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 224: Australia Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Australia Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Australia 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 227: Australia Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Australia Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Australia 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 230: Australia Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Australia Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: Australia 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 233: Australia Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Australia Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: Australia 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • INDIA
    • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 236: India Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: India Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: India 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 239: India Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: India Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: India 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 242: India Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: India Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: India 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 245: India Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: India Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: India 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 248: South Korea Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: South Korea Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: South Korea 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 251: South Korea Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: South Korea Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: South Korea 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 254: South Korea Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: South Korea Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: South Korea 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 257: South Korea Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: South Korea Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: South Korea 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Rest of Asia-Pacific Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Rest of Asia-Pacific 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Rest of Asia-Pacific Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Rest of Asia-Pacific 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Rest of Asia-Pacific Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Rest of Asia-Pacific 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Rest of Asia-Pacific Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Rest of Asia-Pacific 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 272: Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 273: Latin America Historic Review for Peripheral Interventions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Latin America 16-Year Perspective for Peripheral Interventions by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 275: Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Latin America Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Latin America 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 278: Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Latin America Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Latin America 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 281: Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Latin America Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: Latin America 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 284: Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Latin America Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: Latin America 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 287: Argentina Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Argentina Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: Argentina 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 290: Argentina Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Argentina Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: Argentina 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 293: Argentina Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Argentina Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: Argentina 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 296: Argentina Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Argentina Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Argentina 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 299: Brazil Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Brazil Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Brazil 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 302: Brazil Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Brazil Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Brazil 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 305: Brazil Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Brazil Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Brazil 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 308: Brazil Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Brazil Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 310: Brazil 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 311: Mexico Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Mexico Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 313: Mexico 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 314: Mexico Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Mexico Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 316: Mexico 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 317: Mexico Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Mexico Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 319: Mexico 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 320: Mexico Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Mexico Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 322: Mexico 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Rest of Latin America Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 325: Rest of Latin America 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Rest of Latin America Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 328: Rest of Latin America 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Rest of Latin America Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 331: Rest of Latin America 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Rest of Latin America Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 334: Rest of Latin America 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 335: Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 336: Middle East Historic Review for Peripheral Interventions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 337: Middle East 16-Year Perspective for Peripheral Interventions by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 338: Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Middle East Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 340: Middle East 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 341: Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Middle East Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 343: Middle East 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 344: Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Middle East Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 346: Middle East 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 347: Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Middle East Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 349: Middle East 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 350: Iran Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Iran Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 352: Iran 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 353: Iran Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Iran Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 355: Iran 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 356: Iran Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Iran Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 358: Iran 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 359: Iran Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Iran Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 361: Iran 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 362: Israel Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Israel Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 364: Israel 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 365: Israel Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Israel Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 367: Israel 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 368: Israel Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Israel Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 370: Israel 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 371: Israel Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Israel Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 373: Israel 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Saudi Arabia Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 376: Saudi Arabia 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Saudi Arabia Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 379: Saudi Arabia 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Saudi Arabia Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 382: Saudi Arabia 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Saudi Arabia Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 385: Saudi Arabia 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 386: UAE Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: UAE Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 388: UAE 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 389: UAE Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: UAE Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 391: UAE 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 392: UAE Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: UAE Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 394: UAE 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 395: UAE Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: UAE Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 397: UAE 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Rest of Middle East Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 400: Rest of Middle East 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Rest of Middle East Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 403: Rest of Middle East 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Rest of Middle East Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 406: Rest of Middle East 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Rest of Middle East Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 409: Rest of Middle East 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
  • AFRICA
    • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 410: Africa Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Africa Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 412: Africa 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
    • TABLE 413: Africa Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Africa Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 415: Africa 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
    • TABLE 416: Africa Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 417: Africa Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 418: Africa 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
    • TABLE 419: Africa Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 420: Africa Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 421: Africa 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!